VetSheet

腎上腺素

Epinephrine

Levo-epinephrine

α及β腎上腺素受體激動劑IVIMSCIOIntratracheal (IT)IntracardiacCRITopicalInhalation山羊

別名: EpiPen · Twinject · Adrenaline · Epinephrine HCl · Epinephrine bitartrate · Levo-epinephrine · Epinephrinum · L-epinephrine

由 VetSheet 獸醫團隊審訂更新於 2026年4月5日本內容以實證獸醫文獻為本

經審核的 v13 劑量證據

經審核的非計算證據
經審核的非計算證據 (2)

只供證據參考,不會自動計算

Most species/CPR, cardiac arrest

TABLE 127.5. Agent: Epinephrine (1 : 1000). Dosage: 0.5–1 mg/kg IV, IO, IT232. Species/Comments: Most species/CPR, cardiac arrest.

IOITIV
高風險須由已驗證獸醫確認drug_regimen方案年份 2019審核 dose-audit-mader-reviewed-v1

只供證據參考,不會自動計算

Snapping turtles/reduction in time to spontaneous respiration after isoflurane anesthesia

TABLE 127.5. Agent: Epinephrine (1 : 1000). Dosage: 0.1 mg/kg IM106. Species/Comments: Snapping turtles/reduction in time to spontaneous respiration after isoflurane anesthesia.

IM
高風險須由已驗證獸醫確認drug_regimen方案年份 2019審核 dose-audit-mader-reviewed-v1

劑量為持牌獸醫專業人員的臨床參考。請務必對照最新藥品說明書及個別病患確認。

正在為病患診症?VetSheet 的 AI 會把藥物、劑量與療程直接寫入結構化診症筆記。了解 VetSheet 如何運作

概覽

​腎上腺素​(Adrenaline)是由腎上腺髓質產生的強效內源性兒茶酚胺。它是交感神經系統主要的「戰鬥或逃跑」荷爾蒙。

在獸醫學中,它是一種關鍵的救命急救藥物,主要用於:

  • ​心肺腦復甦術 (CPCR):​ 在心搏停止(心室靜止)時恢復自主循環。
  • ​嚴重過敏性休克:​ 透過誘發支氣管擴張和血管收縮,迅速逆轉危及生命的過敏反應。
  • ​局部麻醉輔助劑:​ 添加於局部麻醉劑(如利多卡因)中以引起局部血管收縮,從而延緩全身吸收、延長麻醉效果並減少注射部位出血。

​臨床要點:​ 腎上腺素效力極強且治療指數非常狹窄。必須極度小心確保使用正確的濃度。​切勿將 1:1,000 (1 mg/mL) 濃度與 1:10,000 (0.1 mg/mL) 濃度混淆。​

作用機制

Epinephrine is a direct-acting, non-selective adrenergic agonist that stimulates both alpha (α) and beta (β) receptors via G-protein coupled pathways (activating adenylyl cyclase → ↑ cAMP).

  • ​α1-receptors:​ → Induces profound smooth muscle contraction and vasoconstriction, increasing systemic vascular resistance and blood pressure.
  • ​β1-receptors:​ → Directly stimulates the heart, increasing both chronotropy (heart rate) and inotropy (contractility), which increases cardiac output and myocardial oxygen demand.
  • ​β2-receptors:​ → Relaxes smooth muscle, leading to profound bronchodilation (relieving bronchospasm in anaphylaxis), vasodilation in skeletal muscle, and increased glycogenolysis (raising blood sugar).
  • ​Histamine Antagonism:​ Physiologically antagonizes the effects of histamine released during anaphylaxis.

​Hemodynamic effects depend on the route and rate of administration:​ Rapid IV injection causes direct cardiac stimulation and increased systolic BP. Slow IV infusion produces a modest rise in systolic pressure, a decrease in diastolic pressure, and decreased total peripheral resistance due to dominant β2 effects.

安全性與警告

禁忌症

  • Narrow-angle glaucoma
  • Hypersensitivity to epinephrine
  • Shock due to non-anaphylactoid causes
  • During general anesthesia with halogenated hydrocarbons or cyclopropane
  • During labor (may delay the second stage)
  • Cardiac dilatation or coronary insufficiency
  • Conditions where vasopressors are contraindicated (e.g., thyrotoxicosis, diabetes, hypertension, toxemia of pregnancy)
  • Injection with local anesthetics into small appendages (toes, ears, etc.) due to risk of necrosis

不良反應

  • Anxiety and fear
  • Tremors and excitability
  • Vomiting
  • Hypertension (especially with overdosage)
  • Cardiac arrhythmias (especially with pre-existing heart disease)
  • Hyperuricemia
  • Lactic acidosis (with prolonged use or overdose)
  • Tissue necrosis and sloughing at the injection site (with repeated injections or injection into small appendages)

注意事項

​Hypovolemia:​ Epinephrine is not a substitute for adequate fluid volume replacement therapy. ​Cardiac Rhythms:​ Use with extreme caution in patients with a prefibrillatory cardiac rhythm due to excitatory effects on the heart. While useful in asystole, it can cause ventricular fibrillation; use cautiously in cases of existing ventricular fibrillation. ​Tissue Necrosis:​ Do not inject into small appendages (ears, toes, tails) as profound vasoconstriction can cause ischemic necrosis and sloughing. ​Concentration Errors:​ Always double-check the concentration (1:1,000 vs 1:10,000) before administration to avoid fatal overdoses.

藥物相互作用

Alpha-blockers (phentolamine, phenoxybenzamine, prazosin)

May negate the therapeutic effects of epinephrine.

Alpha-2 agonists (detomidine, dexmedetomidine, xylazine)

Do NOT use epinephrine to treat cardiac effects caused by alpha-2 agonists; may worsen hemodynamics.

General Anesthetics (halogenated hydrocarbons, cyclopropane)

Increased risk of developing severe arrhythmias. Propranolol may be used to treat if they occur.

Antihistamines (diphenhydramine, chlorpheniramine)

May potentiate the effects of epinephrine.

Beta-blockers (propranolol)

May potentiate hypertension and antagonize epinephrine's cardiac and bronchodilating effects.

Digoxin

Increased risk of arrhythmias if used concurrently.

Nitrates

May reverse the pressor effects of epinephrine.

Levothyroxine

May potentiate the effects of epinephrine.

Oxytocic agentsModerate

Hypertension may result if used concurrently.

Other Sympathomimetic agents (isoproterenol)

Should not be administered together as increased toxicity may result.

Phenothiazines

May reverse the pressor effects of epinephrine.

Reserpine

May potentiate the pressor effects of epinephrine.

Tricyclic Antidepressants

May potentiate the effects of epinephrine.

Sympathomimetic aminesMajor

Additive effects leading to potential toxicity

AntihistaminesModerate

May potentiate the effects of adrenaline

ThyroxineModerate

May potentiate the effects of adrenaline

PropranololMajor

May block the beta effects of adrenaline, facilitating an increase in blood pressure

Alpha blocking agentsModerate

May negate or diminish the pressor effects of adrenaline

DiureticsModerate

May negate or diminish the pressor effects of adrenaline

HalothaneMajor

Sensitizes the myocardium, increasing the risk of arrhythmias

Digoxin (high doses)Major

Sensitizes the myocardium, increasing the risk of arrhythmias

Halogenated anesthetics (e.g., Halothane, Isoflurane)Major

Sensitizes the myocardium to catecholamines, increasing the risk of severe ventricular arrhythmias.

Beta-blockers (e.g., Propranolol)Major

Antagonizes the beta-adrenergic effects of epinephrine, leaving unopposed alpha-adrenergic vasoconstriction which can lead to severe hypertension.

Tricyclic antidepressants (e.g., Amitriptyline)Moderate

May potentiate the cardiovascular effects of epinephrine.

Alpha-blockers (e.g., Phentolamine, Acepromazine)Moderate

May reverse the pressor effects of epinephrine, potentially leading to vasodilation and hypotension (epinephrine reversal).

監測

  • Cardiac rate and rhythm (ECG)
  • Respiratory rate and auscultation (especially during anaphylaxis)
  • Urine flow (if possible)
  • Blood pressure
  • Blood gases (if indicated and possible)

藥物動力學

吸收

Well-absorbed following IM or SC administration. IM injections are slightly faster absorbed than SC; massaging the site expedites absorption. Rapidly metabolized in the GI tract and liver after oral administration (not effective PO). SC onset of action is 5-10 minutes. IV onset is immediate.

分佈

Does not cross the blood-brain barrier. Crosses the placenta and is distributed into milk.

代謝

Actions are ended primarily by uptake and metabolism into sympathetic nerve endings. Metabolized in the liver and other tissues by monoamine oxidase (MAO) and catechol-O-methyltransferase (COMT) to inactive metabolites.

排除

Excreted as inactive metabolites.

過量

Clinical signs of overdosage or inadvertent IV administration of SC/IM doses include:

  • Sharp rises in systolic, diastolic, and venous blood pressures
  • Cardiac arrhythmias
  • Pulmonary edema and dyspnea
  • Vomiting, headache, and chest pain
  • Cerebral hemorrhages (due to severe hypertension)
  • Renal failure, metabolic acidosis, and cold skin

​Treatment:​ Because epinephrine has a relatively short duration of effect, treatment is mainly supportive. If necessary, an alpha-adrenergic blocker (e.g., phentolamine) or a beta-adrenergic blocker (e.g., propranolol) can be used to treat severe hypertension and cardiac arrhythmias. Prolonged periods of hypotension may follow, requiring treatment with norepinephrine.

可用產品

劑型

  • Injection solution (1:1,000 / 1 mg/mL)
  • Injection solution (1:10,000 / 0.1 mg/mL)
  • Auto-injectors (0.15 mg, 0.3 mg)
  • Aerosol for inhalation
  • Topical solution
  • Solution for nebulization
  • Ophthalmic preparations

獸醫用

  • Epinephrine HCl for Injection 1 mg/mL (1:1,000) in 1 mL amps/syringes and 10 mL, 30 mL, 100 mL vials (Amtech, Am-Vet, Vedco, Vetus, AgriPharm, Durvet, Bimeda, etc.)

人用標示

  • Epinephrine HCl Solution for Injection: 1 mg/mL (1:1,000) in amps and vials (Adrenalin Chloride)
  • Epinephrine HCl Solution for Injection auto-injectors: 1:1,000 (0.3 mg) (EpiPen, Twinject)
  • Epinephrine HCl Solution for Injection auto-injectors: 1:2,000 (0.15 mg) (EpiPen Jr)
  • Epinephrine HCl Solution for Injection: 1:10,000 (0.1 mg/mL) in syringes and vials
  • Epinephrine bitartrate powder (aerosol) for inhalation
  • Topical solutions
  • Ophthalmic preparations

各地核准狀態

European Union✓ 已核准處方藥EMA
🐕 Dogs🐈 Cats🐴 Horses🐄 Cattle pigs🐑 Sheep

停藥期: cattle meat 0 days · cattle milk 0 days

Commonly referred to as Adrenaline in EU regulatory documents.

United Kingdom✓ 已核准處方藥VMD
🐕 Dogs🐈 Cats🐴 Horses🐄 Cattle pigs🐑 Sheep

停藥期: cattle meat 0 days · cattle milk 0 days

Commonly referred to as Adrenaline.

暫無法規資料: 🇺🇸 US · 🇭🇰 HK · 🇹🇼 TW · 🇯🇵 JP · 🇰🇷 KR · 🇦🇺 AU

儲存與穩定性

Store in tight containers protected from light. Epinephrine will darken (oxidize) upon exposure to light and air. Do not use if the injection is pink, brown, or contains a precipitate. Rapidly destroyed by alkalies or oxidizing agents.

飼主須知

腎上腺素是一種用於嚴重過敏反應(過敏性休克)的救命急救藥物。

  • ​僅限急救使用:​ 如果獸醫為您的寵物開立了預裝注射器(如 EpiPen),請僅在獸醫指示的已知嚴重過敏反應發生時使用。
  • ​立即就醫:​ 即使在注射腎上腺素後,您也必須立即將寵物送往獸醫急診診所。藥效會很快消退,過敏反應可能會復發。
  • ​給藥方式:​ 確保您了解獸醫示範的正確注射技巧(通常是肌肉注射或皮下注射)。
  • ​儲存:​ 避光室溫保存。如果藥物已過期、液體變成粉紅色或棕色,或看到有懸浮微粒,​請勿使用​

VetSheet 藥物參考供持牌獸醫專業人員作臨床決策輔助之用,不能取代專業判斷或廠方最新藥品說明書。